March 01, 2021
Clinicians caring for patients who require short-term mechanical circulatory support (MCS) should take the long view in order to obtain the best outcomes, a new review asserts.
The document, published online today in the
Journal of the American College of Cardiology, gathers the literature on what’s known about MCS, particularly the “emerging” Impella (Abiomed) percutaneous left ventricular assist device (LVAD), and explores how these devices are used in cardiogenic shock, right heart failure, and complex coronary interventions.
It covers wide ground, as the authors note, “from initial patient selection and access-site management to issues that arise during further intensive care treatment such as hemocompatibility, device positioning, and optimizing hemodynamics.”
Nuevo estudio: esta dieta de moda puede ayudar a person…
urgente24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urgente24.com Daily Mail and Mail on Sunday newspapers.
COVID-19 can kill heart muscle cells, interfere with contraction – Washington University School of Medicine in St Louis
wustl.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wustl.edu Daily Mail and Mail on Sunday newspapers.